Mind-NRG's Series B Round

Mind-NRG raised a round of funding on September 04, 2013.

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barr…

Articles about Mind-NRG's Series B Round: